207_Combined course Presentations

UK NCRI RAPID trial

 Initial treatment: 3 x ABVD  Re-assessment: if response, PET scan performed

PET +ve (25.3%)

PET –ve (74.7%)

4th cycle ABVD then IFRT

Randomisation

30 Gy IFRT

No further treatment

N.B. Favourable features according with GHSG criteria were present in 74% of patients randomized to “NFT” (65.1% in patients randomized to 30 Gy IFRT)